Artículos del autor

solaci

Day 3

WOEST: Randomized trial that compared dual therapy versus triple therapy on anticoagulated patients.

A multicenter randomized study, (n = 573), that evaluated the role of aspirin in anticoagulated patients undergoing...
solaci -
Day 3

CORE 320: Diagnostic performance of coronary angiotomography including evaluation of myocardial perfusion versus isolated anatomical assessment.

Review: The CORE-320 multicenter study compared combined angiotomography assessments: anatomical (coronary) and functional (myocardial perfusion) versus anatomical...
solaci -
Day 1

C-PORT E-trial: Estudio randomizado de 18867 pacientes en donde se observó que la angioplastia coronaria en centros sin back up quirúrgico es segura.

Read articleThomas Aversano.2012-03-24
solaci -
Day 3

AFIB ABLATION PILOT: Ablation of Atrial Fibrillation by Radiofrequency.

Review: A European multicenter registry, (mainly in France, Italy and Germany), which included 1,410 patients - evidence...
solaci -
Day 3

PRAGUE-12: Surgical Atrial Ablation: Follow the one-year results.

Review: Two hundred twenty-four patients in a surgical plan, (coronary artery bypass grafting or valve), were randomized...
solaci -
Day 3

FAME II: Ischemia guided (IG) percutaneous coronary intervention (PCI) is superior to medical treatment.

Review: Stable coronary disease remains a scenario where percutaneous coronary intervention, (PCI), has not cleared the edges....
solaci -
Day 2

ACCESS-EUROPE: 12 months results in percutaneous treatment of mitral insufficiency .

Presentation Summary: ACCESS-EUROPE multicenter registry included 567 patients with severe mitral regurgitation treated with Mitral Clip in...
solaci -
Day 2

GRACE: Use of insulin glargine and fatty acids to reduce atherosclerosis progression.

Presentation Summary: There is a clear association between hyperglycemia and the development of atherosclerosis. The GRACE sub...
solaci -